These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 10090437
41. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells]. Kunitama M, Komatsu N, Miura Y. Rinsho Ketsueki; 1996 Nov; 37(11):1314-7. PubMed ID: 8960668 [Abstract] [Full Text] [Related]
42. Cost-effectiveness of primary and secondary prevention in cardiovascular diseases. Troche CJ, Tacke J, Hinzpeter B, Danner M, Lauterbach KW. Eur Heart J; 1998 Apr; 19 Suppl C():C59-65. PubMed ID: 9597427 [Abstract] [Full Text] [Related]
44. Statin wars following coronary revascularization--evidence-based clinical practice? Brophy JM, Costa V. Can J Cardiol; 2006 Jan; 22(1):54-8. PubMed ID: 16450018 [Abstract] [Full Text] [Related]
45. [Which statin is more efficient? Concepts and applications in economic evaluation]. García-Altés A, Jovell AJ. Aten Primaria; 2000 Sep 30; 26(5):333-8. PubMed ID: 11100606 [No Abstract] [Full Text] [Related]
46. Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors. Sonoda Y, Gotow T, Kuriyama M, Nakahara K, Arimura K, Osame M. Muscle Nerve; 1994 Aug 30; 17(8):891-7. PubMed ID: 8041396 [Abstract] [Full Text] [Related]
47. Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy. Devold HM, Molden E, Skurtveit S, Furu K. Br J Clin Pharmacol; 2009 Feb 30; 67(2):234-41. PubMed ID: 19220274 [Abstract] [Full Text] [Related]
48. Pravastatin versus simvastatin--what happens in the real world? Levenstein S. S Afr Med J; 1995 May 30; 85(5):388-91. PubMed ID: 7638696 [No Abstract] [Full Text] [Related]
50. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). Alsheikh-Ali AA, Karas RH. Am J Cardiol; 2007 Feb 01; 99(3):379-81. PubMed ID: 17261402 [Abstract] [Full Text] [Related]
51. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study. Einarson TR, Metge CJ, Iskedjian M, Mukherjee J. Clin Ther; 2002 Dec 01; 24(12):2126-36. PubMed ID: 12581550 [Abstract] [Full Text] [Related]
55. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A. Med Clin (Barc); 1995 Nov 25; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]
58. Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment. Ramirez C, Tercero I, Pineda A, Burgos JS. J Alzheimers Dis; 2011 Nov 25; 24(1):161-74. PubMed ID: 21224519 [Abstract] [Full Text] [Related]